NovoCure
(NASDAQ) NVCR
NovoCure Financials at a Glance
Market Cap
$1.89BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$674.41M
Net Income (TTM)
-$173.05M
EPS (TTM)
-$1.53
P/E Ratio
-10.62
Dividend
$0.00
Beta (Volatility)
1.45 (Average)
Dividend
$0.00
Beta (Volatility)
1.45 (Average)
Price
$16.34
Volume
1,948,450.846
Open
$17.20
Price
$16.34
Volume
1,948,450.846
Open
$17.20
Previous Close
$16.30
Daily Range
$16.01 - $17.35
52-Week Range
$9.82 - $18.92
Estimated Earnings Date
Jul 23, 2026
Dividend
$0.00
Beta (Volatility)
1.45 (Average)
Price
$16.34
Volume
1,948,450.846
Open
$17.20
Previous Close
$16.30
Daily Range
$16.01 - $17.35
52-Week Range
$9.82 - $18.92
Estimated Earnings Date
Jul 23, 2026
NVCR News
NVCR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NovoCure
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
1,605
CEO
Frank Leonard
Website
www.novocure.comHeadquarters
Baar, 6340, CH
NVCR Financials
Key Financial Metrics (TTM)
Gross Margin
75.20%
Operating Margin
-27.19%
Net Income Margin
-25.66%
Return on Equity
-50.82%
Return on Capital
-24.39%
Return on Assets
-21.96%
Earnings Yield
-9.42%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.89BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
115.82M
Volume
1.95M
Avg. Volume
1.73M
Financials (TTM)
Gross Profit
$507.13M
Operating Income
-$183.36M
EBITDA
-$155.38M
Operating Cash Flow
-$26.88M
Capital Expenditure
-$21.19M
Free Cash Flow
-$48.07M
Cash & ST Invst.
$441.80M
Total Debt
$234.94M
NovoCure Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$174.06M
+12.3%
Gross Profit
$135.13M
+16.0%
Gross Margin
77.63%
N/A
Market Cap
$1.89BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.18M
N/A
Employees
1,605
N/A
Net Income
-$71.14M
-107.3%
EBITDA
-$63.30M
-134.7%
Quarterly Fundamentals
Total Cash
$441.80M
-52.6%
Total Debt
$234.94M
-66.3%
Accounts Receivable
$93.27M
-21.3%
Inventory
$43.46M
+10.1%
Long Term Debt
$234.94M
+70.5%
Short Term Debt
$0.00
-100.0%
Return on Assets
-21.96%
N/A
Return on Invested Capital
-32.15%
N/A
Free Cash Flow
-$18.67M
+59.7%
Operating Cash Flow
-$13.52M
+62.1%